Download this FREE whitepaper for comparative data and valuable insider insights that pharma companies should consider for their products and marketing strategies.
Participate in this short, ten minute survey on data access and analytics in health plans today. Input from professionals in the field is important, and we appreciate your participation.
As the number of clinical trials increases so does the complexity and number of US and global sites needed to foster trial success. Read what was discovered after a survey on current site payment practices, how these practices are measured, what process improvement initiatives are currently being explored, what are some of the barriers to change, and what site payment trends will occur over the next five years. Download it now!
Download this infographic for comparative data and valuable insider insights on dermatology drug adherence that pharma companies should consider for their products and marketing strategies.
Take this quick 10 minute survey on the state of sales enablement in the healthcare industry. A $5 Amazon Gift Card will be sent to the first 50 qualified respondents. Complete the survey now!
Hear new results from one of the industry's largest, global clinical operations surveys, the Veeva 2018 Unified Clinical Operations Survey. The Veeva 2018 Unified Clinical Operations Survey examines the industry’s progress toward a unified clinical operating environment. Register Now
Learn why unifying clinical applications is an industrywide priority for clinical operations leaders. Read the report.
Research tells us that the role of patient-physician communication is a key factor that can impact adherence.
Download this Infographic to learn how Atlantis Healthcare uses health psychology to improve patient-physician communication and drive higher rates of treatment adherence.
Join Joe Lipari, Director - Global Traceability from Systech, as we map out a proven route to serialization success along with Steve Kane, Head of Product Integrity Program Global IT for Shire and Ann Schaefer, Director - Supply Chain Management at Acorda Therapeutics. The panel will discuss complexity of the regulations, hurdles they overcame, and solutions that carried them over the finish line. Register Now.
Researchers are encumbered with a plethora of disparate data and analytic tools. These assets pose several challenges which need to be overcome to ensure they satisfy their intended purpose.
Watch this webinar to learn how real-time, self-service access to longitudinal patient data is changing the way researchers evaluate treatment effectiveness, safety, protocol design, and more. Register now.
“Faster and better” has become the mantra for biopharmaceutical companies as they face intense pressure to get therapies to market faster. Quickly proving efficacy in first-in-human (FIH) trials is a make-or-break milestone for these cash-strapped companies whose hopes hinge upon one or two molecules. Read how CDMOs are responding to this pressure.
The new EU HTA Directive requires consistent comparative clinical efficacy assessment of EMA assessed treatments. Understand the history of the Directive, what is included, the proposed structure and timing, potential implications for industry and stakeholders, and how to prepare. Register now.
Watch a video to learn how to incorporate everything you need to progress you drug candidate from late stage discovery to phase I into one comprehensive offering which can quickly help achieve your milestone
Read a case study on how to utilize a parallel screening approach to selecting a most suitable formulation technology for an early phase BCS Class II compound. The molecule was advanced to animal study with enhanced bioavailability in 12 weeks.
Advancing beyond Phase I can be exciting – and eye opening – for clinical sponsors. By examining study factors known to be leading indicators of future clinical supply challenges, sponsors can take a proactive approach to clinical supplies, build realistic timelines and better forecast demand.
Study sponsors often focus on upfront planning to ensure clinical sites are prepared to reach study milestones but ignore the logical challenges of managing their clinical returns. Learn how developing a forward-thinking plan to manage clinical returns can reduce study close out risk.
Download this Infographic for comparative data and valuable insider insights on gastrointestinal drug adherence that pharma companies should consider for their products and marketing strategies.
Read Deloitte Consulting's whitepaper on the value of a holistic RIM capability, covering the potential cost savings and revenue gains from doing RIM right.
This action-oriented webinar will describe in detail the information investigators, sponsors, and service providers need to meet technical requirements, support collaborations, and understand each other’s needs and expectations—providing a pathway forward to make the use of mobile technologies in clinical trials a reality. Register now!
A case of 29X increase in relative effectiveness
Dave Taylor, director of market research at Inspire, describes case studies illustrating how life science companies can reduce the time it takes to conduct research by accessing a website that millions of patients flock to. Learn more.
Gartner research on preparing for IDMP
While the deadline for IDMP compliance is delayed, life sciences IT leaders supporting regulatory compliance can use this research to establish value-adding strategies for the short – and long – term. Read it now.